NNC 45-0095
NNC 45-0095 is a chemical compound that belongs to the class of calcium channel blockers. It was developed by the Novo Nordisk company, hence the prefix "NNC" in its name. This compound is known for its selective inhibitory effect on the T-type calcium channel, which plays a crucial role in various physiological processes.
History
NNC 45-0095 was first synthesized and studied by the Danish pharmaceutical company Novo Nordisk. The company is known for its extensive research in the field of pharmacology and drug discovery, with a particular focus on diabetes and other metabolic disorders.
Pharmacology
NNC 45-0095 is a potent and selective inhibitor of the T-type calcium channel. Calcium channels are protein complexes that facilitate the movement of calcium ions across cell membranes. The T-type calcium channel is one of the several types of calcium channels found in the body. It is characterized by its transient opening and closing, hence the name "T-type" (transient type).
The inhibition of T-type calcium channels by NNC 45-0095 has been found to have potential therapeutic applications. For instance, it has been suggested that this compound could be used in the treatment of certain types of epilepsy, as well as in the management of pain and hypertension.
Clinical significance
The clinical significance of NNC 45-0095 lies in its potential therapeutic applications. Its ability to selectively inhibit T-type calcium channels makes it a promising candidate for the development of new drugs for the treatment of various disorders, including epilepsy, pain, and hypertension.
However, as of now, NNC 45-0095 is primarily used in research settings. Further studies are needed to fully understand its pharmacological properties and potential therapeutic benefits.
See also
NNC_45-0095
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
